Vanita Noronha

47PUBLICATIONS
200CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Statistical theoryPredictive and prognostic markersRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Aug 09, 2026
Lessons learned from the use of capecitabine-based triplet neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.

|Jul 31, 2026
Reply to: Statistical and Methodological Considerations in the Evaluation of Ultra-Low-Dose Nivolumab.

|Jul 09, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

|Jun 17, 2026
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).

|May 21, 2026
Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer.

|May 14, 2026
Translating Innovation Into Practice: Dissemination of Immune Checkpoint Inhibitors and Their Toxicity Management Across the Globe.

Pageof 8

Frequent Collaborators

31 joint publications

Kumar Prabhash

23 joint publications

Nandini Sharrel Menon

15 joint publications

Vijay Patil

11 joint publications

Akhil Kapoor